806 related articles for article (PubMed ID: 30098941)
1. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
[TBL] [Abstract][Full Text] [Related]
2. Quinoline derivatives: Synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action.
Coimbra ES; Antinarelli LM; Silva NP; Souza IO; Meinel RS; Rocha MN; Soares RP; da Silva AD
Chem Biol Interact; 2016 Dec; 260():50-57. PubMed ID: 27789199
[TBL] [Abstract][Full Text] [Related]
3. Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis.
Stroppa PHF; Antinarelli LMR; Carmo AML; Gameiro J; Coimbra ES; da Silva AD
Bioorg Med Chem; 2017 Jun; 25(12):3034-3045. PubMed ID: 28433512
[TBL] [Abstract][Full Text] [Related]
4. Solidagenone acts on promastigotes of L. amazonensis by inducing apoptosis-like processes on intracellular amastigotes by IL-12p70/ROS/NO pathway activation.
Bortoleti BTDS; Gonçalves MD; Tomiotto-Pellissier F; Contato VM; Silva TF; de Matos RLN; Detoni MB; Rodrigues ACJ; Carloto AC; Lazarin DB; Arakawa NS; Costa IN; Conchon-Costa I; Miranda-Sapla MM; Wowk PF; Pavanelli WR
Phytomedicine; 2021 May; 85():153536. PubMed ID: 33765552
[TBL] [Abstract][Full Text] [Related]
5. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
[TBL] [Abstract][Full Text] [Related]
6. 4-Aminoquinoline Derivatives as Potential Antileishmanial Agents.
Antinarelli LM; Dias RM; Souza IO; Lima WP; Gameiro J; da Silva AD; Coimbra ES
Chem Biol Drug Des; 2015 Oct; 86(4):704-14. PubMed ID: 25682728
[TBL] [Abstract][Full Text] [Related]
7. Novel steroid derivatives: synthesis, antileishmanial activity, mechanism of action, and in silico physicochemical and pharmacokinetics studies.
da Trindade Granato J; Dos Santos JA; Calixto SL; Prado da Silva N; da Silva Martins J; da Silva AD; Coimbra ES
Biomed Pharmacother; 2018 Oct; 106():1082-1090. PubMed ID: 30119174
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol analogues present effective antileishmanial activity against promastigotes and amastigotes from distinct Leishmania species by multitarget action in the parasites.
Antinarelli LMR; Meinel RS; Coelho EAF; da Silva AD; Coimbra ES
J Pharm Pharmacol; 2019 Dec; 71(12):1854-1863. PubMed ID: 31595530
[TBL] [Abstract][Full Text] [Related]
9. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
[TBL] [Abstract][Full Text] [Related]
10. Novel functionalized 1,2,3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis.
Meinel RS; Almeida ADC; Stroppa PHF; Glanzmann N; Coimbra ES; da Silva AD
Chem Biol Interact; 2020 Jan; 315():108850. PubMed ID: 31634447
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of novel 4-aminoquinoline/1,2,3-triazole hybrids against Leishmania amazonensis.
Glanzmann N; Antinarelli LMR; da Costa Nunes IK; Pereira HMG; Coelho EAF; Coimbra ES; da Silva AD
Biomed Pharmacother; 2021 Sep; 141():111857. PubMed ID: 34323702
[TBL] [Abstract][Full Text] [Related]
12. Antileishmanial activity of a 4-hydrazinoquinoline derivative: Induction of autophagy and apoptosis-related processes and effectiveness in experimental cutaneous leishmaniasis.
Antinarelli LMR; de Oliveira Souza I; Zabala Capriles PV; Gameiro J; Britta EA; Nakamura CV; Lima WP; da Silva AD; Coimbra ES
Exp Parasitol; 2018 Dec; 195():78-86. PubMed ID: 30385267
[TBL] [Abstract][Full Text] [Related]
13. Grandiflorenic acid promotes death of promastigotes via apoptosis-like mechanism and affects amastigotes by increasing total iron bound capacity.
Bortoleti BTDS; Gonçalves MD; Tomiotto-Pellissier F; Miranda-Sapla MM; Assolini JP; Carloto ACM; de Carvalho PGC; Cardoso ILA; Simão ANC; Arakawa NS; Costa IN; Conchon-Costa I; Pavanelli WR
Phytomedicine; 2018 Jul; 46():11-20. PubMed ID: 30097110
[TBL] [Abstract][Full Text] [Related]
14. 4-Quinolinylhydrazone analogues kill Leishmania (Leishmania) amazonensis by inducing apoptosis and mitochondria-dependent pathway cell death.
Granato JDT; Silva ETD; Lemos ASO; Machado PA; Midlej VDV; Antinarelli LMR; Silva Neto AFD; Souza MVN; Coimbra ES
Chem Biol Drug Des; 2024 May; 103(5):e14535. PubMed ID: 38772877
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
16. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
18. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978
[TBL] [Abstract][Full Text] [Related]
19. Dehydroabietic acid isolated from Pinus elliottii exerts in vitro antileishmanial action by pro-oxidant effect, inducing ROS production in promastigote and downregulating Nrf2/ferritin expression in amastigote forms of Leishmania amazonensis.
Gonçalves MD; Bortoleti BTS; Tomiotto-Pellissier F; Miranda-Sapla MM; Assolini JP; Carloto ACM; Carvalho PGC; Tudisco ET; Urbano A; Ambrósio SR; Hirooka EY; Simão ANC; Costa IN; Pavanelli WR; Conchon-Costa I; Arakawa NS
Fitoterapia; 2018 Jul; 128():224-232. PubMed ID: 29802873
[TBL] [Abstract][Full Text] [Related]
20. Parasitological and immunological evaluation of a quinoline derivative salt incorporated into a polymeric micelle formulation against Leishmania infantum infection.
Ribeiro Antinarelli LM; Glanzmann N; Mendonça DVC; Lage DP; Oliveira-da-Silva JA; Tavares GSV; Carvalho AMRS; Freitas CS; Martins VT; Duarte MC; Menezes-Souza D; da Silva AD; Coelho EAF; Soares Coimbra E
Parasitol Res; 2022 Jul; 121(7):2129-2140. PubMed ID: 35614147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]